|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/75 | |
| A61K 31/44 | |||
| A61P 7/00 |
| (11) | Number of the document | 2513058 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10801495.2 |
| Date of filing the European patent application | 2010-12-15 | |
| (97) | Date of publication of the European application | 2012-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/060572 |
| Date | 2010-12-15 |
| (87) | Number | WO 2011/084519 |
| Date | 2011-07-14 |
| (30) | Number | Date | Country code |
| 287680 P | 2009-12-17 | US |
| (72) |
PANDEY, Anjali, US
LEITAO, Emilia, P., T., PT
RATO, Jose, PT
SONG, Zhiguo, Jake, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Portola Pharmaceuticals, Inc., 270 East Grand Avenue Suite 22, South San Francisco, California 94080, US |
| (54) | METHODS OF SYNTHESIZING FACTOR XA INHIBITORS |
| METHODS OF SYNTHESIZING FACTOR XA INHIBITORS |